OraSure Technologies EBITDA Margin 2010-2025 | OSUR
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for OraSure Technologies (OSUR) over the last 10 years. The current EBITDA margin for OraSure Technologies as of March 31, 2025 is .
| OraSure Technologies EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $0.16B | $-0.03B | -17.39% |
| 2024-12-31 | $0.19B | $-0.02B | -9.19% |
| 2024-09-30 | $0.22B | 0 | 0.00% |
| 2024-06-30 | $0.27B | $0.02B | 6.23% |
| 2024-03-31 | $0.30B | $0.02B | 6.91% |
| 2023-12-31 | $0.41B | $0.05B | 13.09% |
| 2023-09-30 | $0.45B | $0.07B | 14.38% |
| 2023-06-30 | $0.48B | $0.06B | 11.69% |
| 2023-03-31 | $0.47B | $0.03B | 7.17% |
| 2022-12-31 | $0.39B | $-0.01B | -1.55% |
| 2022-09-30 | $0.33B | $-0.03B | -9.45% |
| 2022-06-30 | $0.27B | $-0.05B | -17.29% |
| 2022-03-31 | $0.24B | $-0.02B | -9.84% |
| 2021-12-31 | $0.24B | $0.00B | 0.43% |
| 2021-09-30 | $0.23B | $0.02B | 7.26% |
| 2021-06-30 | $0.23B | $0.03B | 14.91% |
| 2021-03-31 | $0.20B | $0.02B | 11.56% |
| 2020-12-31 | $0.17B | $0.00B | 2.33% |
| 2020-09-30 | $0.16B | 0 | 0.00% |
| 2020-06-30 | $0.15B | $0.01B | 5.44% |
| 2020-03-31 | $0.16B | $0.02B | 14.01% |
| 2019-12-31 | $0.16B | $0.03B | 16.77% |
| 2019-09-30 | $0.16B | $0.03B | 21.29% |
| 2019-06-30 | $0.17B | $0.03B | 18.79% |
| 2019-03-31 | $0.17B | $0.03B | 18.24% |
| 2018-12-31 | $0.18B | $0.03B | 18.68% |
| 2018-09-30 | $0.18B | $0.03B | 17.93% |
| 2018-06-30 | $0.18B | $0.03B | 16.11% |
| 2018-03-31 | $0.18B | $0.03B | 17.05% |
| 2017-12-31 | $0.17B | $0.05B | 27.54% |
| 2017-09-30 | $0.15B | $0.04B | 28.67% |
| 2017-06-30 | $0.14B | $0.04B | 30.00% |
| 2017-03-31 | $0.13B | $0.04B | 30.53% |
| 2016-12-31 | $0.13B | $0.03B | 21.26% |
| 2016-09-30 | $0.12B | $0.02B | 19.35% |
| 2016-06-30 | $0.12B | $0.02B | 15.57% |
| 2016-03-31 | $0.12B | $0.02B | 14.05% |
| 2015-12-31 | $0.12B | $0.01B | 11.76% |
| 2015-09-30 | $0.12B | $0.01B | 6.03% |
| 2015-06-30 | $0.11B | $0.01B | 6.14% |
| 2015-03-31 | $0.11B | $0.01B | 6.36% |
| 2014-12-31 | $0.11B | $0.00B | 1.87% |
| 2014-09-30 | $0.11B | $0.01B | 10.28% |
| 2014-06-30 | $0.10B | $0.01B | 7.69% |
| 2014-03-31 | $0.10B | 0 | 0.00% |
| 2013-12-31 | $0.10B | $-0.01B | -5.05% |
| 2013-09-30 | $0.09B | $-0.02B | -18.48% |
| 2013-06-30 | $0.09B | $-0.02B | -20.22% |
| 2013-03-31 | $0.09B | $-0.02B | -18.18% |
| 2012-12-31 | $0.09B | $-0.01B | -10.23% |
| 2012-09-30 | $0.09B | $0.00B | -3.33% |
| 2012-06-30 | $0.09B | $-0.01B | -5.56% |
| 2012-03-31 | $0.09B | $-0.01B | -5.81% |
| 2011-12-31 | $0.08B | $-0.01B | -6.10% |
| 2011-09-30 | $0.08B | $-0.01B | -9.09% |
| 2011-06-30 | $0.07B | $0.00B | -4.05% |
| 2011-03-31 | $0.07B | $0.00B | -1.35% |
| 2010-12-31 | $0.08B | $0.00B | -1.33% |
| 2010-09-30 | $0.08B | $0.00B | -5.19% |
| 2010-06-30 | $0.08B | $0.00B | -3.75% |
| 2010-03-31 | $0.08B | $-0.01B | -8.97% |
| 2009-12-31 | $0.08B | $-0.01B | -7.79% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.217B | $0.186B |
| OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.329B | 27.82 |
| Boston Scientific (BSX) | United States | $151.540B | 37.94 |
| Stryker (SYK) | United States | $146.015B | 30.53 |
| EssilorLuxottica (ESLOY) | France | $127.709B | 0.00 |
| Medtronic (MDT) | Ireland | $109.786B | 15.56 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.554B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.214B | 28.03 |
| ResMed (RMD) | United States | $36.648B | 27.53 |
| Agilent Technologies (A) | United States | $32.650B | 21.28 |
| GE HealthCare Technologies (GEHC) | United States | $32.569B | 15.46 |
| Terumo (TRUMY) | Japan | $26.857B | 34.88 |
| Insulet (PODD) | United States | $22.464B | 88.18 |
| Koninklijke Philips (PHG) | Netherlands | $21.600B | 15.53 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.095B | 11.62 |
| Baxter (BAX) | United States | $15.380B | 11.48 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.819B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.043B | 21.03 |
| Lantheus Holdings (LNTH) | United States | $5.509B | 13.90 |
| Prestige Consumer Healthcare (PBH) | United States | $4.190B | 18.72 |
| Perrigo (PRGO) | Ireland | $3.610B | 9.15 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.346B | 15.24 |
| ICU Medical (ICUI) | United States | $3.233B | 23.84 |
| Envista Holdings (NVST) | United States | $3.178B | 26.41 |
| GN Store Nord (GNNDY) | Denmark | $2.155B | 17.85 |
| QuidelOrtho (QDEL) | United States | $2.102B | 14.46 |
| LeMaitre Vascular (LMAT) | United States | $1.865B | 41.69 |
| AtriCure (ATRC) | United States | $1.729B | 0.00 |
| Acuren (TIC) | United States | $1.228B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.196B | 12.14 |
| Green Thumb Industries (GTBIF) | United States | $1.101B | 24.76 |
| Neogen (NEOG) | United States | $1.077B | 13.78 |
| BioLife Solutions (BLFS) | United States | $1.046B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.016B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.972B | 12.42 |
| InMode (INMD) | Israel | $0.931B | 9.38 |
| Evolus (EOLS) | United States | $0.632B | 0.00 |
| CeriBell (CBLL) | United States | $0.619B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.571B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.564B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.563B | 0.00 |
| Valneva SE (VALN) | France | $0.523B | 0.00 |
| Owens & Minor (OMI) | United States | $0.515B | 4.27 |
| Surmodics (SRDX) | United States | $0.429B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.412B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.340B | 12.52 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.313B | 55.70 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.291B | 0.00 |
| Cerus (CERS) | United States | $0.275B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.272B | 22.90 |
| Sanara MedTech (SMTI) | United States | $0.260B | 0.00 |
| ZimVie (ZIMV) | United States | $0.255B | 11.61 |
| Cresco Labs (CRLBF) | United States | $0.250B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.239B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.231B | 0.00 |
| Quanterix (QTRX) | United States | $0.217B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.205B | 0.00 |
| Brainsway (BWAY) | Israel | $0.198B | 52.30 |
| Omeros (OMER) | United States | $0.196B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.195B | 0.00 |
| Biote (BTMD) | United States | $0.194B | 5.45 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 14.80 |
| Organigram Global (OGI) | Canada | $0.179B | 0.00 |
| Exagen (XGN) | United States | $0.157B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 16.72 |
| Vireo Growth (VREOF) | United States | $0.125B | 0.00 |
| Jin Medical (ZJYL) | China | $0.121B | 0.00 |
| Veru (VERU) | United States | $0.096B | 0.00 |
| MacroGenics (MGNX) | United States | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.56 |
| TerrAscend (TSNDF) | Canada | $0.089B | 0.00 |
| Agape ATP (ATPC) | $0.077B | 0.00 | |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Zynex (ZYXI) | United States | $0.065B | 0.00 |
| Apyx Medical (APYX) | United States | $0.063B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.045B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.02 |
| Nephros (NEPH) | United States | $0.035B | 47.43 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.021B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |